- Home
- COYA
as 11-24-2025 10:06am EST
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 125.1M | IPO Year: | 2022 |
| Target Price: | $15.80 | AVG Volume (30 days): | 203.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.65 - $8.29 | Next Earning Date: | 11-12-2025 |
| Revenue: | $3,987,706 | Revenue Growth: | -58.26% |
| Revenue Growth (this year): | 40.8% | Revenue Growth (next year): | -86.75% |
Latest Coya Therapeutics Inc. News
COYA Breaking Stock News: Dive into COYA Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
RoboMarkets expands trading opportunities with over 1,300 additional US stocks and ETFs
Business Wire
12 days ago
Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
Business Wire
20 days ago
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo
Insider Monkey
a month ago
Here’s Greenlight Capital’s Update on Coya Therapeutics (COYA)
Business Wire
a month ago
Coya Therapeutics Announces Closing of $23.0 Million Upsized Public Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
MT Newswires
a month ago
Investors Digest September Inflation Report, Lifting US Equity Futures Pre-Bell
MT Newswires
a month ago
Coya Therapeutics Prices $20 Million Public Offering of Common Stock; Shares Fall Pre-Bell
MT Newswires
a month ago
Top Premarket Decliners
Compare COYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COYA Coya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.